EULAR 2024
June 12-15, 2024 | Vienna, Austria
New insights on the impact of tapering GCs or immunosuppressive therapy on damage accrual after achieving LLDAS and complete remission SLE
Validation of IMACS guidelines for enhanced cancer screening: A Hong Kong myositis cohort